Predictive oncology stock.

Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model.The company owns a biorepository of tumor samples, a lab and a good manufacturing practice ...Predictive Oncology Inc (NASDAQ:POAI) 3.22 Delayed Data As of 4:00pm ET +0.13 / +4.21% Today’s Change 2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date …Here are just a few of the top artificial intelligence (AI) stocks to buy and hold today.Predictive Oncology (): The company could be a game-changer in cancer drug development. C3.ai (): After a ...The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...

The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ...

Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today …

4 analysts have issued 12 month price targets for Ikena Oncology's stock. Their IKNA share price targets range from $11.00 to $13.00. On average, they expect the company's share price to reach $11.67 in the next twelve months. This suggests a possible upside of 677.8% from the stock's current price.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology Inc (POAI) stock is higher by 5.43% while the S&P 500 has fallen -0.81% as of 1:18 PM on Monday, Jan 30. POAI has risen $0.02 from the previous closing price of $0.46 on volume of 290,855 shares. Over the past year the S&P 500 has fallen -10.58% while POAI has fallen -45.45%.Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ...Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.

May 26, 2023 · Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model. The company owns a biorepository of tumor samples, a lab and a good manufacturing ...

Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to improve risk stratification in oncology. We characterized evidence-based use cases of predictive …

Your vote is important and easy to cast. Vote Now! Please enter your control number to view/cast your vote. Control Number. Log In ...Assess the Predictive Oncology stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month POAI price targets.Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ...The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... December 01, 2021 at 08:31 am EST. EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, today announced the acquisition of zPREDICTA, a company pioneering tumor-specific in vitro 3D cell culture models ...

Based on 79,403,893 shares of common stock issued and outstanding as of March 17, 2023, immediately following the Reverse Stock Split, the Company would have approximately 39,701,947 shares of common stock issued and outstanding (without giving effect to rounding for fractional shares) if the ratio for the Reverse Stock Split is one-for- …The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...4 Wall Street analysts have issued 1 year target prices for Pyxis Oncology's stock. Their PYXS share price targets range from $7.00 to $14.00. On average, they anticipate the company's share price to reach $10.50 in the next twelve months. This suggests a possible upside of 629.2% from the stock's current price.The estimated Net Worth of J Melville Engle is at least $86.4 Tisíc dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $83,391 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ...Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ...

The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. 17 days ago • Morningstar View morePredictive Oncology (NASDAQ:POAI) on Thursday said it would effect a 1-for-20 reverse stock split.The stock split will become effective on April 24. "The reverse stock split is primarily intended ...

The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ...Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Information on stock, financials, earnings, subsidiaries, investors, and executives for Predictive Oncology. Use the PitchBook Platform to explore the full ...About Predictive Oncology (NASDAQ: POAI) The leading edge of a new frontier in drug discovery As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to … About us Read More » The estimated Net Worth of Richard L Gabriel is at least $54.5 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $52,142 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.Predictive Oncology Inc. (POAI) is a science-driven company that leverages its AI and machine learning capabilities to accelerate oncologic drug discovery and enable drug development. The stock price, news, quote and history of POAI are shown on Yahoo Finance, as well as related research and analysis.Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...

Predictive Oncology Inc. (POAI) is a science-driven company that leverages its AI and machine learning capabilities to accelerate oncologic drug discovery and enable drug development. The stock price, news, quote and history of POAI are shown on Yahoo Finance, as well as related research and analysis.

Jul 18, 2023 · Predictive Oncology Inc. PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and ...

Predictive Oncology Inc (POAI) Stock Price & News - Google Finance Home POAI • NASDAQ Predictive Oncology Inc Follow Share $2.98 Nov 24, 5:45:00 PM GMT-5 · USD · NASDAQ · Disclaimer search... Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 2:08 PM on Friday, Mar 31, a gain of $0.01, or 3.39% from the previous closing price of $0.28. The stock has traded between $0.28 and $0.30 so far today. Volume today is below average. So far 218,615 shares have traded compared to average volume of 340,765 shares.In the digital age, music has become more accessible than ever before. With just a few clicks, you can stream your favorite songs or even download them for offline listening. In the early days of digital music, users had to pay a fee to dow...The Predictive Oncology stock forecast is 4.3910063584427 USD for 2024 November 25, Monday; and 14.588 USD for 2028 November 25, Saturday with technical analysis. Predictive Oncology (POAI) stock price prediction is 4.3910063584427 USD.ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.Raymond Vennare POAI stock SEC Form 4 insiders trading. Raymond has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Raymond bought 5,000 units of POAI stock worth $2,600 on 2 December 2022.. The largest trade Raymond's ever made was buying 5,000 units …See the latest Predictive Oncology Inc stock price (POAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Jun 27, 2023 · Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ... The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.What's Thomas Goldrick's mailing address? Thomas's mailing address filed with the SEC is 2915 COMMERS DRIVE, SUITE 900, , EAGAN, MN, 55121.Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ...

A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with UPMC Magee-Womens Hospital. The objective of the study was to evaluate the use of AI to build multi-omic machine learning (ML) models …Admittedly, Gilead is starting from scratch in oncology, with only three approved products - for context, Bristol Myers Squibb markets and sells 9 major oncology products, which will likely drive ...Instagram:https://instagram. instacart competitorsday to day trading appexdividendbest e banking app Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here. trade options roth irafidelity semiconductor Nov 18, 2023 · Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […] top renewable energy stocks Predictive Oncology’s revenue increased by 45% to $455,000 in the most recent quarter, but the company continues to produce substantial losses. Thus, this is a relatively high-risk, high-upside ...Predictive Oncology's (NASDAQ:POAI) declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock for each outstanding common share held of record, as of March 27.